Hilco Vision Acquires Simovision BV

Windjammer Capital Acquires Hilco Vision

September 10, 2019

Healthcare Services

Windjammer Capital Investors has acquired Hilco Vision (The Hilsinger Company) in partnership with Hilco management; terms were not disclosed. Windjammer positions Hilco as a platform investment to accelerate growth through organic initiatives and strategic acquisitions in the eyecare/optical distribution market.

Hilco Vision (Windjammer Portfolio) Acquires Suppleyes

June 1, 2020

Medical Devices

Hilco Vision, a portfolio company of Windjammer Capital Investors, has acquired Suppleyes, an ophthalmic supplies distributor based in Madison, Mississippi. Suppleyes will be integrated into Hilco’s ophthalmic supplies subsidiary Eye Care and Cure to broaden Hilco’s product portfolio and national distribution for eye care professionals; terms were not disclosed.

Hilco Vision Acquires Bruder Healthcare

September 17, 2021

Medical Devices

Hilco Vision, a portfolio company of Windjammer Capital Investors, has acquired Bruder Healthcare effective September 17, 2021; terms were not disclosed. Bruder, a maker of therapeutic and ophthalmic dry-eye products based in Alpharetta, Georgia, will be integrated into Hilco’s product portfolio as the transaction represents a PE-backed add-on to expand Hilco’s offerings to eye care professionals and consumers.

Hilco Vision (Windjammer Portfolio) Acquires M&S Technologies

January 7, 2021

Medical Devices

Hilco Vision, a portfolio company of Windjammer Capital Investors, has acquired M&S Technologies (MST), a developer of digital vision testing systems and clinical trial software. The acquisition — an add-on to Hilco Vision’s eyecare platform — will keep MST headquartered in Niles, Illinois, with founders Joe and Karen Marino remaining in leadership roles.

Avista Capital Partners and VHC Investco Acquire Vision Healthcare NV

June 1, 2020

Consumer Products

Avista Capital Partners, together with VHC Investco and company management, acquired Belgium-based Vision Healthcare NV in a transaction valuing the company at €305 million (approximately $336 million). Avista and VHC Investco/management will each hold a 50% ownership interest; the partnership will support Vision's omni-channel, direct-to-consumer growth and geographic expansion across Europe and beyond.

Vision Healthcare Acquires Sensilab

April 13, 2021

Consumer Products

Vision Healthcare has agreed to acquire 100% of Sensilab d.o.o., a Ljubljana-headquartered direct-to-consumer house of consumer health brands (including Sensilab, SlimJoy, Tummy Tox and PowGen). Sensilab reported approximately €44m in net sales in 2020 and operates in-house manufacturing; the add-on strengthens Vision Healthcare’s pan‑European D2C vitamins, supplements and beauty platform and pushes group revenue above €200m.